Association of genetic variants with chronic kidney disease in individuals with different lipid profiles

International Journal of Molecular Medicine

Volumn 24, Issue 2, 2009, Pages 233-246

  Yoshida, Tetsuro ^a   Kato, Kimihiko ^b   Yokoi, Kiyoshi ^b   Oguri, Mitsutoshi ^c   Watanabe, Sachiro ^d   Metoki, Norifumi ^e   Yoshida, Hidemi ^f   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Nishigaki, Yutaka ^g   Nozawa, Yoshinori ^h   Yamada, Yoshiji ⁱ  

^a Inabe General Hospital   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Hirosaki Stroke Center   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

ⁱ MIE UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; End stage renal disease; Genetics; High density lipoprotein cholesterol; Lipid profile; Low density lipoprotein cholesterol; Polymorphism; Triglyceride

Indexed keywords

GENE PRODUCT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN ROCK2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABC TRANSPORTER A1; ARYLDIALKYLPHOSPHATASE; INTERSTITIAL COLLAGENASE; INWARDLY RECTIFYING POTASSIUM CHANNEL; LIPID; MMP1 PROTEIN, HUMAN; PON1 PROTEIN, HUMAN; RHO KINASE; ROCK2 PROTEIN, HUMAN;

AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; LINKAGE ANALYSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; GENE FREQUENCY; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

AGED; ARYLDIALKYLPHOSPHATASE; ATP-BINDING CASSETTE TRANSPORTERS; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RHO-ASSOCIATED KINASES; TRIGLYCERIDES;

EID: 70349314604     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000226     Document Type: Article

References (40)

1. Weiner DE, Tighiouart H, Amin MG, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004.
2. Jafar TH, Stark PC, Schmid CH, et al: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139: 244-252, 2003.
3. Iseki K, Oshiro S, Tozawa M, Ikemiya Y, Fukiyama K and Takishita S: Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res 25: 185-190, 2002.
4. Moranne O, Watier L, Rossert J, Stengel B and GN-Progress Study Group: Primary glomerulonephritis: an update on renal survival and determinants of progression. Q J Med 101: 215-224, 2008.
5. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ and Coresh J: Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14: 2934-2941, 2003.
6. Yamagata K, Ishida K, Sairenchi T, et al: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71: 159-166, 2007.
7. Muntner P, Coresh J, Smith JC, Eckfeldt J and Klag MJ: Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58: 293-301, 2000.
8. Schaeffner ES, Kurth T, Curhan GC, et al: Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14: 2084-2091, 2003.
9. De Jong PE and Brenner BM: From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 66: 2109-2118, 2004.
10. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2 Suppl 1): 1-266, 2002.
11. Gharavi AG, Yan Y, Scolari F, et al: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354-357, 2000.
12. Hanson RL, Craig DW and Millis MP: Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56: 975-983, 2007.
13. Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S and Tokunaga K: Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 17: 823-830, 2006.
14. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O and Johansen KL: Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 68: 278-284, 2005.
15. Imai E, Matsuo S, Makino H, et al: Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 31: 1101-1107, 2008.
16. Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
17. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
18. Noma K, Oyama N and Liao JK: Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 290: C661-C668, 2006.
19. Rankinen T, Church T, Rice T, Markward N, Blair SN and Bouchard C: A major haplotype block at the rho-associated kinase 2 locus is associated with a lower risk of hypertension in a recessive manner: the HYPGENE study. Hypertens Res 31: 1651-1657, 2008.
20. Seasholtz TM, Wessel J, Rao F, et al: Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 47: 937-947, 2006.
21. Hattersley AT and Ashcroft FM: Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54: 2503-2513, 2005.
22. Gloyn AL, Pearson ER, Antcliff JF, et al: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350: 1838-1849, 2004.
23. + channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 41: 1511-1515, 1998.
24. Barbato E, Piscione F, Bartunek J, et al: Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 111: 288-294, 2005.
25. Kato N, Sugiyama T, Morita H, et al: Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 37: 286-292, 2001.
26. He X, Lu Y, Saha N, Yang H and Heng CK: Acyl-CoA: cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks. Hum Genet 118: 393-403, 2005.
27. Anderson RA, Joyce C, Davis M, et al: Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem 273: 26747-26754, 1998.
28. Burnett JR, Wilcox LJ, Telford DE, et al: Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. J Lipid Res 40: 1317-1327, 1999.
29. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
30. Rutter JL, Mitchell TI, Butticè G, et al: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58: 5321-5325, 1998.
31. Pearce E, Tregouet DA, Samnegård A, et al: Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 97: 1070-1076, 2005.
32. Armstrong C, Abilleira S, Sitzer M, Markus HS and Bevan S: Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke 38: 2895-2899, 2007.
33. Männistö PT and Kaakkola S: Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51: 593-628, 1999.
34. Eriksson AL, Skrtic S, Niklason A, et al: Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 25: 386-391, 2004.
35. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL and Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250, 1996.
36. Reddy ST, Wadleigh DJ, Grijalva V, et al: Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21: 542-547, 2001.
37. Wheeler JG, Keavney BD, Watkins H, Collins R and Danesh J: Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363: 689-695, 2004.
38. Ranade K, Kirchgessner TG, Iakoubova OA, et al: Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 36: 2346-2350, 2005.
39. Irace C, Cortese C, Fiaschi E, et al: The influence of PON1 192 polymorphism on endothelial function in diabetic subjects with or without hypertension. Hypertens Res 31: 507-513, 2008.
40. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13: 1663-1672, 2002.